Bharat Biotech Gets Restricted Emergency Use Authorisation in Children For COVAXIN
The expert panel of the central drug regulator has recommended that Bharat Biotech's Covaxin be given marketing authorization with conditions for restricted emergency use (EUA) in children and adolescents aged two to eighteen years. But, top government sources stated on Tuesday that the ultimate approval of EUA from the drug authority and inclusion of the vaccine in the